Reversible or irreversible remodeling in pulmonary arterial hypertension.
about
Insight into Pulmonary Arterial Hypertension Associated with Congenital Heart Disease (PAH-CHD): Classification and Pharmacological Management from a Pediatric Cardiological Point of ViewApelin-APJ signaling: a potential therapeutic target for pulmonary arterial hypertensionSex differences in the pulmonary circulation: implications for pulmonary hypertensionRecapitulation of developing artery muscularization in pulmonary hypertension.PK10453, a nonselective platelet-derived growth factor receptor inhibitor, prevents the progression of pulmonary arterial hypertension.A Case Series of Young Patients with Completely Reversed Severe Pulmonary Hypertension.Egr-1 expression during neointimal development in flow-associated pulmonary hypertension.CXCR4 inhibition ameliorates severe obliterative pulmonary hypertension and accumulation of C-kit⁺ cells in ratsRole of Hypoxia-Induced Brain Derived Neurotrophic Factor in Human Pulmonary Artery Smooth MuscleSmooth muscle cell progenitors are primed to muscularize in pulmonary hypertension.Determinants of an elevated pulmonary arterial pressure in patients with pulmonary arterial hypertensionmiR-21 regulates chronic hypoxia-induced pulmonary vascular remodeling.Oxidant signaling for interleukin-13 gene expression in lung smooth muscle cellsPulmonary artery smooth muscle cell proliferation and migration in fetal lambs acclimatized to high-altitude long-term hypoxia: role of histone acetylationActivation of AMPK Prevents Monocrotaline-Induced Extracellular Matrix Remodeling of Pulmonary Artery.BIX-01294 treatment blocks cell proliferation, migration and contractility in ovine foetal pulmonary arterial smooth muscle cells.Selective class I histone deacetylase inhibition suppresses hypoxia-induced cardiopulmonary remodeling through an antiproliferative mechanism.IL-22 activates oxidant signaling in pulmonary vascular smooth muscle cellsMicroRNAs in pulmonary arterial remodelingSmooth muscle contractile diversity in the control of regional circulations.BDNF secretion by human pulmonary artery endothelial cells in response to hypoxia.Vascular repair and regeneration as a therapeutic target for pulmonary arterial hypertensionThe role of disturbed blood flow in the development of pulmonary arterial hypertension: lessons from preclinical animal models.Stem cells of the adult lung: their development and role in homeostasis, regeneration, and disease.Development and pathologies of the arterial wall.Neuron-derived orphan receptor 1 promoted human pulmonary artery smooth muscle cells proliferation.A critical role for Egr-1 during vascular remodelling in pulmonary arterial hypertension.Transient Receptor Potential Channel 4 Encodes a Vascular Permeability Defect and High-Frequency Ca(2+) Transients in Severe Pulmonary Arterial Hypertension.Cigarette smoke extract stimulates rat pulmonary artery smooth muscle cell proliferation via PKC-PDGFB signaling.Targeting the adventitial microenvironment in pulmonary hypertension: A potential approach to therapy that considers epigenetic change.Sodium butyrate inhibits platelet-derived growth factor-induced proliferation and migration in pulmonary artery smooth muscle cells through Akt inhibition.Reactive Oxygen Species in COPD-Related Vascular Remodeling.Possible role of increased oxidative stress in pulmonary hypertension in experimental diaphragmatic hernia.Implication of PDGF signaling in cigarette smoke-induced pulmonary arterial hypertension in rat.Stress Analysis-Driven Design of Bilayered Scaffolds for Tissue-Engineered Vascular Grafts.Endothelial cell-related autophagic pathways in Sugen/hypoxia-exposed pulmonary arterial hypertensive rats.MicroRNA-145-targeted drug and its preventive effect on pulmonary arterial hypertension (patent WO2012153135 A1).Isolation and characterization of endothelial-to-mesenchymal transition cells in pulmonary arterial hypertension.Evaluation of WO-2014132220, selective PDGFR inhibitors for the treatment of pulmonary arterial hypertension.Characteristics of Pulmonary Vascular Remodeling in a Novel Model of Shunt-Associated Pulmonary Arterial Hypertension.
P2860
Q26749283-274610AF-5472-4CAF-8A6A-858A726E9B48Q27010531-9C57BBD5-50E2-4B8F-8E85-3E7AB1287C31Q33568826-325155BA-BBE2-460A-B38A-21684F4F16C1Q33587457-90DE07BF-5D34-4A38-83E5-DDE9E0F63CECQ33805920-4046AE14-263A-4AFE-8706-0325BFB7B16BQ33832243-AA2B01C1-CC5A-4882-8D8E-1ACEE49E5399Q34021089-75808873-2B3B-4EF3-B26D-67FF9AB9BD38Q35108148-42334C47-F1CA-43B3-BCB7-114F1B5CF113Q35698710-E459DC38-BDFE-47DA-B872-9C6F2C373372Q35800881-FA949FC9-D526-4CEB-8FD7-8DF553E6D656Q35825326-B56EE0B9-3713-40BA-8B91-2A0193D3D755Q35850316-FE0A2D3D-434E-42D2-A8E4-1FCDEBDB4FC2Q35926109-B0ED2DBB-63D4-495A-B778-0AA767FA794AQ36494609-0F03A877-9DA9-471A-ABB3-DEE9ED6B9F7EQ36695298-14DB27CF-4070-4FAB-979D-DED9CF17416BQ36831427-6B36335C-A6E0-4D21-8F25-B6F8FE3AF5E5Q36929766-FF6AFD95-4D88-4588-850E-EEA552AF4EB3Q37281476-233534CF-23DD-41AB-8FC5-D92C4616E415Q37308092-6101EE18-100F-41F2-ACFD-E1DB4AAC4272Q37575852-60D85C4E-1ECE-4C6C-85BF-63EF129AEDF9Q37688363-F2A31D4B-56B5-482A-A48F-6EF8F5BBDF9DQ38099709-467FDA5C-43D4-41AF-9637-2259FD756B00Q38102555-EF47BA58-AA04-4385-8E92-6BD182595EECQ38116936-73EAC374-3C3F-4707-B863-74A2361224A6Q38144750-69E53088-3DE6-4BDF-917A-3601B6A2E8E5Q38299957-A2D0D0AF-A667-44F7-A970-EDC4D172751DQ39159352-19ED6716-8169-4964-951E-B53A8C3BB02BQ41841126-CAE4EA49-7A11-4FE8-A6D1-E5C72575E791Q41952153-864E7947-B0E7-4517-AB87-B02CD5FD1A23Q42145272-28A38384-860E-494E-AC9C-7C2A0E7562D7Q45352755-1F844AFC-7C5B-40AA-84A8-36C1E41D0F03Q46280803-1C058961-6BE6-4FFD-8FE3-596026158F8CQ46644212-4CFE2735-E465-4E94-84E9-77629A88720FQ47434568-27FBE591-E4BB-4FC9-A672-2A771514919DQ47698272-B9433EF1-4ACD-4E66-8255-3991EF942ED2Q47966441-747C448B-DE18-4A22-9439-12C729875760Q48045287-01626C37-A5BC-4410-A7FD-E2EEB5708D28Q48313046-EBA33D49-209D-4852-9E74-9B8DED4B0C2AQ48533276-F071E6E2-8878-4238-B690-446B88F639A7Q51733063-406BB4AA-F5DF-40E9-97D6-8ED4673408D6
P2860
Reversible or irreversible remodeling in pulmonary arterial hypertension.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Reversible or irreversible remodeling in pulmonary arterial hypertension.
@en
Reversible or irreversible remodeling in pulmonary arterial hypertension.
@nl
type
label
Reversible or irreversible remodeling in pulmonary arterial hypertension.
@en
Reversible or irreversible remodeling in pulmonary arterial hypertension.
@nl
prefLabel
Reversible or irreversible remodeling in pulmonary arterial hypertension.
@en
Reversible or irreversible remodeling in pulmonary arterial hypertension.
@nl
P2093
P2860
P356
P1476
Reversible or irreversible remodeling in pulmonary arterial hypertension.
@en
P2093
Koichiro Tatsumi
Norbert F Voelkel
Seiichiro Sakao
P2860
P304
P356
10.1165/RCMB.2009-0389TR
P577
2009-12-11T00:00:00Z